SCHEMBL5899752

SCHEMBL5899752

NCC1(C(=O)O)CC1CCCOc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.41
PARP10 Q53GL7 1/20 0.41
KCNA3 P22001 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
ALOX12 P18054 1/20 0.38
CPB2 Q96IY4 1/20 0.38
RECQL P46063 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899794 0.93 TAAR1 (0.43) TAAR1PARP10KCNA3SMN1; SMN2ALDH1A1
SCHEMBL5899627 0.84 TDP1 (0.40) TAAR1PARP10SMN1; SMN2KDM4EPKM
SCHEMBL5899569 0.78 ALDH1A1 (0.34) ALDH1A1
SCHEMBL5899802 0.77 SLC1A2 (0.42) TAAR1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL5899749 0.73 SLC6A4 (0.40) ALDH1A1HPGDCPB2
SCHEMBL5899762 0.72 ARG1 (0.34) ALDH1A1
SCHEMBL5899650 0.71 SLC6A2 (0.33)
SCHEMBL5899581 0.69 GRM2 (0.33)
SCHEMBL5899706 0.68 TAAR1 (0.39) TAAR1SMN1; SMN2ALDH1A1KDM4EPKM
SCHEMBL5899598 0.68 TAAR1 (0.40) TAAR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US disclosed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives CACNA1S, CACNA1D, CACNA1B TAAR1 611/4885PARP10 3340/4885KCNA3 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.